Prolong Pharmaceuticals LLC is categorized under in South Plainfield, NJ and active since 2009.
Prolong Pharmaceuticals LLC was established in 2009, and today employs 1 to 4, earning Unknown per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Abraham Abuchowski, Chief Executive Officer at the company’s single location by writing to 300 Corporate Court # B, South Plainfield, New Jersey NJ 07080 or by phoning (908) 753-5493. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Prolong Pharmaceuticals LLC |
| Contact Person: | Abraham Abuchowski, Chief Executive Officer |
| Address: | 300 Corporate Court # B, South Plainfield, New Jersey 07080 |
| Phone Number: | (908) 753-5493 |
| Website Address: | prolongpharmaceuticals.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 5417112 |
| Share This Business: |
Prolong Pharmaceuticals LLC was started in 2009 to provide professional under the SIC code 2834 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Abraham Abuchowski, Chief Executive Officer for inquiries that concern Prolong Pharmaceuticals LLC by calling the company number (908) 753-5493, as your correspondence is most welcome. Additionally, the physical location of the single location of Prolong Pharmaceuticals LLC can be found at the coordinates 40.54974,-74.42279 as well as the street address 300 Corporate Court # B in South Plainfield, New Jersey 07080.
For its online presence, you may visit Prolong Pharmaceuticals LLC’s website at prolongpharmaceuticals.com and engage with its social media outlets through on Twitter and on Facebook.